Health In Tech (HIT) Cash & Equivalents (2023 - 2026)

Health In Tech has reported Cash & Equivalents for 4 years, with the latest figure at $6.5 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 19.95% year-over-year to $6.5 million in Q2 2026; TTM through Jun 2026 was $6.5 million, a 19.95% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, down 2.29% from the prior year.
• Cash & Equivalents was $6.5 million for Q2 2026 at Health In Tech, down from $7.7 million in the prior quarter.
• The five-year high for Cash & Equivalents was $8.1 million in Q2 2025, with the low at $2.4 million in Q4 2023.
• Average Cash & Equivalents over 4 years is $6.9 million, with a median of $7.7 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents surged 224.84% in 2024, then fell 19.95% in 2026.
• Over 4 years, Cash & Equivalents stood at $2.4 million in 2023, then soared by 224.84% to $7.8 million in 2024, then declined by 2.29% to $7.7 million in 2025, then retreated by 15.06% to $6.5 million in 2026.
• The last three Cash & Equivalents figures came in at $6.5 million (Q2 2026), $7.7 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.